Bladmir 25 Tablet ER
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Mirabegron (25mg)
Overview Bladmir 25 Tablet ER
Overactive bladder symptoms, such as frequent urination, urgency, and incontinence, are managed with Bladmir 25 ER tablets. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your doctor's prescribed dosage and duration; it may be taken with or without food. Swallow the tablet whole—do not crush or chew. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, nasal congestion, urinary tract infections, tachycardia, and arthralgia. Report persistent or bothersome side effects promptly to your physician. Prior to commencing treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups under medical supervision.
Uses of Bladmir 25 Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Bladmir 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Bladmir 25 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. While Bladmir 25 Tablet ER can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Bladmir 25 Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Bladmir 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Bladmir 25 ER Tablets. These tablets should be swallowed whole; do not chew, crush, or divide them. While Bladmir 25 ER Tablets can be administered with or without food, consistent timing is recommended for optimal results.
How Bladmir 25 Tablet ER works:
Bladmir 25 Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's mechanism of action involves stimulating bladder beta-3 receptors, resulting in detrusor muscle relaxation and consequently reducing urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Bladmir 25 Tablet ER with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The extended-release Bladmir 25 Tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Bladmir 25 mg tablets are likely unsafe for breastfeeding mothers. Preliminary human studies indicate potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Bladmir 25 ER tablets.
KidneyCAUTION
For individuals with severe kidney impairment, the extended-release Bladmir 25 Tablet requires careful administration. A modified dosage of Bladmir 25 Tablet ER might be necessary. Physician consultation is recommended.
LiverCAUTION
Exercise caution when prescribing Bladmir 25 Tablet ER to patients with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Bladmir 25 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Bladmir 25 Tablet ER :
Should you forget a dose of Bladmir 25 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bladmir 25 Tablet ER
| Label | Value |
|---|---|
| Type of Compound | Aromatic Amide |
| Potential for Dependence | None. |
| Type of Medication | The study of the urinary tract and male reproductive system. |
| Mechanism of Action | Beta-3 adrenergic receptor-selective activator (urinary bladder) |



